9th NovAliX Conference | Hybrid Event

Committee

Conference Chairman

Chairman

Dr Jean-Paul RENAUD (Urania Therapeutics, Ostwald, France)

Scientific Committee

Members

Prof. Michelle ARKIN (University of California, San Francisco, CA, United States)
Dr Claudio CIFERRI (Genentech, South San Francisco, United States)
Dr MariJean EGGEN (Eli Lilly, Indianapolis, United States)
Dr Daniel ERLANSON (Frontier Medicines, San Francisco, United States)
Dr Jean-Paul RENAUD (Urania Therapeutics, Ostwald, France)
Dr Holly SOUTTER (Broad Institute, Cambridge, United States)
Dr Chaohong SUN (Abbvie, North Chicago, United States)
Dr Daniel WYSS (Merck & Co., Inc., Morristown, United States)

Organized by

Copyright 2024 LD Organisation srl  |  rue Michel de Ghelderode 33/02 B-1348  Louvain-la-Neuve (Belgium)  Tel. +32 (0)10 45 47 77  |   |  VAT: BE 0464819842
Developed and powered by Antalys